Summary
Baker Hughes Company (BKR) has filed a Current Report on Form 8-K to disclose significant updates regarding its Board of Directors and corporate governance. The primary event is the appointment of Dr. Mohsen M. Sohi as a new independent director to the Board, effective January 25, 2023. Dr. Sohi brings extensive executive leadership experience, currently serving as CEO of Freudenberg SE and holding directorial roles, including Chairman of STERIS plc. His appointment is intended to enhance the Board's expertise. Additionally, the company has updated its corporate bylaws, adopting the Fifth Amended and Restated Bylaws. These changes are primarily to align with updates in Delaware General Corporate Law and to implement new SEC regulations, specifically Rule 14a-19, which governs proxy access and related disclosures for shareholder proposals. These amendments aim to streamline governance processes and ensure compliance with evolving regulatory requirements.
Key Highlights
- 1Dr. Mohsen M. Sohi appointed as an independent director to the Board of Directors.
- 2Dr. Sohi brings significant executive experience as CEO of Freudenberg SE and chairman of STERIS plc.
- 3Dr. Sohi will serve on the Human Capital and Compensation Committee.
- 4Baker Hughes' Board of Directors adopted the Fifth Amended and Restated Bylaws, effective January 25, 2023.
- 5Bylaw amendments update for changes in Delaware General Corporate Law.
- 6Bylaw amendments implement edits related to SEC Rule 14a-19 concerning proxy access and shareholder proposals.
- 7Dr. Sohi's compensation will be consistent with other non-employee directors.